These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 10434891)
1. Measurement of c-myc oncogene expression provides an accurate prognostic marker for acral lentiginous melanoma. Grover R; Chana J; Grobbelaar AO; Hudson DA; Forder M; Wilson GD; Sanders R Br J Plast Surg; 1999 Mar; 52(2):122-6. PubMed ID: 10434891 [TBL] [Abstract][Full Text] [Related]
2. The clinical significance of c-myc oncogene expression in melanomas of the scalp. Chana JS; Grover R; Wilson GD; Hudson DA; Forders M; Sanders R; Grobbelaar AO Br J Plast Surg; 1998 Apr; 51(3):191-4. PubMed ID: 9664877 [TBL] [Abstract][Full Text] [Related]
3. Use of oncogene expression as an independent prognostic marker for primary melanoma. Grover R; Pacifico MD; Wilson GD; Sanders R Ann Plast Surg; 2003 Feb; 50(2):183-7. PubMed ID: 12567057 [TBL] [Abstract][Full Text] [Related]
4. A prospective analysis of c-myc oncoprotein levels as a prognostic marker in malignant melanoma. Ramsden AJ; Grover R; Chana J; Tulley P; Sanders R; Wilson GD J Plast Reconstr Aesthet Surg; 2007; 60(6):626-30. PubMed ID: 17485049 [TBL] [Abstract][Full Text] [Related]
5. Expression of c-myc oncoprotein represents a new prognostic marker in cutaneous melanoma. Ross DA; Wilson GD Br J Surg; 1998 Jan; 85(1):46-51. PubMed ID: 9462382 [TBL] [Abstract][Full Text] [Related]
6. An analysis of p16 tumour suppressor gene expression in acral lentiginous melanoma. Chana JS; Grover R; Wilson GD; Hudson DA; Forders M; Sanders R; Grobbelaar AO Br J Plast Surg; 2000 Jan; 53(1):46-50. PubMed ID: 10657449 [TBL] [Abstract][Full Text] [Related]
7. Long-term prognostic significance of HSP-70, c-myc and HLA-DR expression in patients with malignant melanoma. Ricaniadis N; Kataki A; Agnantis N; Androulakis G; Karakousis CP Eur J Surg Oncol; 2001 Feb; 27(1):88-93. PubMed ID: 11237497 [TBL] [Abstract][Full Text] [Related]
8. Cancer-testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rate. Svobodová S; Browning J; MacGregor D; Pollara G; Scolyer RA; Murali R; Thompson JF; Deb S; Azad A; Davis ID; Cebon JS Eur J Cancer; 2011 Feb; 47(3):460-9. PubMed ID: 21115342 [TBL] [Abstract][Full Text] [Related]
9. Gene expression profiling of primary cutaneous melanoma and clinical outcome. Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A; J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783 [TBL] [Abstract][Full Text] [Related]
10. HSP-70, C-myc and HLA-DR expression in patients with cutaneous malignant melanoma metastatic in lymph nodes. Kalogeraki A; Garbagnati F; Darivianaki K; Delides GS; Santinami M; Stathopoulos EN; Zoras O Anticancer Res; 2006; 26(5A):3551-4. PubMed ID: 17094481 [TBL] [Abstract][Full Text] [Related]
11. The clinical significance of oncogene expression in subungual melanoma. Grover R; Grobbelaar AO; Hudson DA; Forder M; Wilson GD; Sanders R Br J Plast Surg; 1997 Jan; 50(1):15-9. PubMed ID: 9038509 [TBL] [Abstract][Full Text] [Related]
12. Nuclear survivin is associated with disease recurrence and poor survival in patients with cutaneous malignant melanoma. Piras F; Murtas D; Minerba L; Ugalde J; Floris C; Maxia C; Colombari R; Perra MT; Sirigu P Histopathology; 2007 Jun; 50(7):835-42. PubMed ID: 17543072 [TBL] [Abstract][Full Text] [Related]
13. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases. Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396 [TBL] [Abstract][Full Text] [Related]
14. Long term follow-up of c-myc, p53 and proliferation measurements in malignant melanoma. Ross DA; Laing JH; Sanders R; Wilson GD Eur J Surg Oncol; 2006 Feb; 32(1):80-4. PubMed ID: 16256294 [TBL] [Abstract][Full Text] [Related]
15. Association of high molecular weight melanoma-associated antigen expression in primary acral lentiginous melanoma lesions with poor prognosis. Kageshita T; Kuriya N; Ono T; Horikoshi T; Takahashi M; Wong GY; Ferrone S Cancer Res; 1993 Jun; 53(12):2830-3. PubMed ID: 8504426 [TBL] [Abstract][Full Text] [Related]
16. Stratification of patients by melanoma cell adhesion molecule (MCAM) expression on the basis of risk: implications for sentinel lymph node biopsy. Pearl RA; Pacifico MD; Richman PI; Wilson GD; Grover R J Plast Reconstr Aesthet Surg; 2008; 61(3):265-71. PubMed ID: 17569608 [TBL] [Abstract][Full Text] [Related]
17. Acral lentiginous melanoma: histopathological prognostic features of 121 cases. Phan A; Touzet S; Dalle S; Ronger-Savlé S; Balme B; Thomas L Br J Dermatol; 2007 Aug; 157(2):311-8. PubMed ID: 17596173 [TBL] [Abstract][Full Text] [Related]
18. The developmentally regulated neural crest-associated glycotope HNK-1 predicts metastasis in cutaneous malignant melanoma. Thies A; Schachner M; Berger J; Moll I; Schulze HJ; Brunner G; Schumacher U J Pathol; 2004 Aug; 203(4):933-9. PubMed ID: 15258996 [TBL] [Abstract][Full Text] [Related]
19. Thick cutaneous malignant melanoma: a reappraisal of prognostic factors. Massi D; Borgognoni L; Franchi A; Martini L; Reali UM; Santucci M Melanoma Res; 2000 Apr; 10(2):153-64. PubMed ID: 10803716 [TBL] [Abstract][Full Text] [Related]
20. Prognostic relevance of P-cadherin expression in melanocytic skin tumours analysed by high-throughput tissue microarrays. Bauer R; Wild PJ; Meyer S; Bataille F; Pauer A; Klinkhammer-Schalke M; Hofstaedter F; Bosserhoff AK J Clin Pathol; 2006 Jul; 59(7):699-705. PubMed ID: 16565225 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]